(1R,2R,3S,4R,5S)-1-methyl-4-(6-(phenethylamino)-2-(phenylethynyl)-9H-purin-9-yl)bicyclo[3.1.0]hexane-2,3-diol

ID: ALA4559342

Chembl Id: CHEMBL4559342

PubChem CID: 155558029

Max Phase: Preclinical

Molecular Formula: C28H27N5O2

Molecular Weight: 465.56

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  C[C@@]12C[C@@H]1[C@@H](n1cnc3c(NCCc4ccccc4)nc(C#Cc4ccccc4)nc31)[C@H](O)[C@@H]2O

Standard InChI:  InChI=1S/C28H27N5O2/c1-28-16-20(28)23(24(34)25(28)35)33-17-30-22-26(29-15-14-19-10-6-3-7-11-19)31-21(32-27(22)33)13-12-18-8-4-2-5-9-18/h2-11,17,20,23-25,34-35H,14-16H2,1H3,(H,29,31,32)/t20-,23-,24+,25+,28-/m1/s1

Standard InChI Key:  JLDGDSNQAUZZKE-NGWPRWDKSA-N

Alternative Forms

  1. Parent:

    ALA4559342

    ---

Associated Targets(Human)

TMEM97 Tchem Sigma intracellular receptor 2 (973 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADORA3 Tchem Adenosine A3 receptor (15931 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADORA2A Tclin Adenosine A2a receptor (16305 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADORA1 Tclin Adenosine A1 receptor (17603 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SLC6A2 Tclin Norepinephrine transporter (10102 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Adora3 Adenosine A3 receptor (257 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Adora2a Adenosine A2a receptor (87 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Adora1 Adenosine A1 receptor (162 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 465.56Molecular Weight (Monoisotopic): 465.2165AlogP: 3.18#Rotatable Bonds: 5
Polar Surface Area: 96.09Molecular Species: NEUTRALHBA: 7HBD: 3
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 13.28CX Basic pKa: 2.98CX LogP: 4.34CX LogD: 4.34
Aromatic Rings: 4Heavy Atoms: 35QED Weighted: 0.39Np Likeness Score: 0.18

References

1. Yu J, Mannes P, Jung YH, Ciancetta A, Bitant A, Lieberman DI, Khaznadar S, Auchampach JA, Gao ZG, Jacobson KA..  (2018)  Structure activity relationship of 2-arylalkynyl-adenine derivatives as human A3 adenosine receptor antagonists.,  (11): [PMID:30568760] [10.1039/C8MD00317C]

Source